XERIJECT Trademark

Trademark Overview

On Friday, December 4, 2020, a trademark application was filed for XERIJECT with the United States Patent and Trademark Office. The USPTO has given the XERIJECT trademark a serial number of 90359515. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERIJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders
xeriject

General Information

Serial Number90359515
Word MarkXERIJECT
Filing DateFriday, December 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events

Event DateEvent Description
Tuesday, December 8, 2020NEW APPLICATION ENTERED
Wednesday, February 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, May 12, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 26, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 26, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 26, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, May 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 16, 2021SOU EXTENSION 1 FILED
Thursday, December 16, 2021SOU EXTENSION 1 GRANTED
Saturday, December 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 27, 2022SOU EXTENSION 2 FILED
Friday, May 27, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 31, 2023SOU EXTENSION 3 FILED
Tuesday, January 31, 2023SOU EXTENSION 3 GRANTED
Thursday, August 24, 2023SOU EXTENSION 4 FILED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 24, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, September 12, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 24, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 12, 2023SOU EXTENSION 4 GRANTED
Wednesday, September 13, 2023CORRECTED NOA E-MAILED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU EXTENSION 5 FILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 5 GRANTED
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

xeriject diseases pharmaceutical treatment preparations conditions system namely antineoplastic vaccines infections